Joanne Berdzik

Suggest Changes
Learn More
With a goal of identifying relations between gene expression and response (mucosal or pathological) or survival in esophageal cancer patients (stages II to IV) receiving oxaliplatin, 5-fluorouracil(More)
4014 Background: In a study designed to explore the relationship between expression of TS, γGCS, γGT, ERCC-1 and XPA genes and clinical outcome for 38 pts with PEC, who received OXP (85 mg/m2 day(More)
PURPOSE To identify a dose and schedule of oxaliplatin (OXP) to be safely administered in combination with protracted-infusion (PI) fluorouracil (5-FU) and external-beam radiation therapy (XRT) for(More)
  • 1